1. Home
  2. UFG vs LIXT Comparison

UFG vs LIXT Comparison

Compare UFG & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uni-Fuels Holdings Limited

UFG

Uni-Fuels Holdings Limited

HOLD

Current Price

$0.85

Market Cap

29.7M

Sector

Energy

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

N/A

Current Price

$3.07

Market Cap

25.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UFG
LIXT
Founded
2021
2005
Country
Singapore
United States
Employees
17
4
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
25.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UFG
LIXT
Price
$0.85
$3.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
249.9K
38.1K
Earning Date
04-22-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.40
N/A
Revenue Next Year
$25.00
N/A
P/E Ratio
$211.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.64
52 Week High
$9.91
$6.09

Technical Indicators

Market Signals
Indicator
UFG
LIXT
Relative Strength Index (RSI) 42.12 55.83
Support Level $0.78 $2.97
Resistance Level $1.29 $3.30
Average True Range (ATR) 0.07 0.24
MACD -0.01 0.05
Stochastic Oscillator 29.64 80.88

Price Performance

Historical Comparison
UFG
LIXT

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: